Home Archives 2011

Yearly Archives: 2011

I will be teaching Biotechnology Management (TECH 566) again this spring at the National Institutes of Health Foundation for Advanced Education in the Sciences. The focus of this course is on learning the skills necessary to succeed in the biotechnology industry. Classes are comprised of a combination of lectures based on my textbook, Building Biotechnology, and guest lectures from local entrepreneurs, financiers, and biotechnology company management.

Classes start on January 25th, and are held on Tuesday evenings in the NIH Office of Technology Transfer offices. For more details, see TECH 566 in the FAES course catalog.

Drug Patent Expirations in January 2011

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent Number Patent Expiration
VITRAVENE PRESERVATIVE FREENovartisfomivirsen sodium5,276,019Jan 4, 2011
ELIGARDTolmar Therapleuprolide acetate5,278,201Jan 11, 2011
ULTIVABioniche Teorantaremifentanil hydrochloride5,019,583*PEDJan 12, 2011
XELODAHoffmann La Rochecapecitabine4,966,891Jan 13, 2011
DUETACTTakeda Globalglimepiride; pioglitazone hydrochloride4,687,777Jan 17, 2011
ACTOSTakeda Pharms Napioglitazone hydrochloride4,687,777Jan 17, 2011
ACTOPLUS METTakeda Globalmetformin hydrochloride; pioglitazone hydrochloride4,687,777Jan 17, 2011
ACTOPLUS MET XRTakeda Globalmetformin hydrochloride; pioglitazone hydrochloride4,687,777Jan 17, 2011
PROTONIX IVWyeth Pharms Incpantoprazole sodium4,758,579*PEDJan 19, 2011
PROTONIXWyeth Pharms Incpantoprazole sodium4,758,579*PEDJan 19, 2011
EMENDMerckaprepitant5,145,684Jan 25, 2011
MEGACE ESPar Pharmmegestrol acetate5,145,684Jan 25, 2011
TRICORAbbottfenofibrate5,145,684Jan 25, 2011
VFENDPfizervoriconazole5,773,443Jan 25, 2011
BAYCOLBayer Pharmscerivastatin sodium5,177,080Jan 26, 2011

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com